Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication
Potential Side Effects, Safety Profile, and Regulatory Status of BPC 157 In preclinical studies, BPC 157 caused mild local irritation at the site of administration, which was the most commonly reported side effect but did not appear to lead to long-term issues
Higher concentrations (3-4%+) are for experienced users who have established tolerance
one study showed that a 1:9 ratio of Ethylhexylglycerin to Phenoxyethanol damages bacterial membranes as effectively as doubling the Phenoxyethanol concentration on its own
Use of BPC-157 will result in an anti-doping rule violation
